デフォルト表紙
市場調査レポート
商品コード
1381011

POC脂質検査市場:コンポーネント、適応症、エンドユーザー別-2023~2030年の世界予測

POC Lipid Testing Market by Component (Instruments, Software), Indication (Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia), End-User - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 183 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.94円
POC脂質検査市場:コンポーネント、適応症、エンドユーザー別-2023~2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 183 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

POC脂質検査市場は、2022年の2億9,954万米ドルから2030年には4億8,015万米ドルに達すると予測され、予測期間中のCAGRは6.07%です。

POC脂質検査の世界市場

主な市場の統計
市場金額:基準年[2022年] 2億9,954万米ドル
推定市場金額[2023年] 3億1,541万米ドル
予測市場金額[2030年] 4億8,015万米ドル
CAGR(%) 6.07%
POC脂質検査 Market-IMG1

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはPOC脂質検査市場の評価に不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。洞察により、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度:新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています:

1.POC脂質検査市場の市場規模および予測は?

2.POC脂質検査市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は?

3.POC脂質検査市場における競争戦略枠組みとは?

4.POC脂質検査市場の最新技術動向と規制の枠組みは?

5.POC脂質検査市場における主要ベンダーの市場シェアは?

6.POC脂質検査市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で心血管疾患の有病率が増加
      • 民間および公共部門による医療への投資の増加
    • 抑制要因
      • POC脂質検査商品の製造に伴う高コスト
    • 機会
      • 医療業界におけるポイントオブケア脂質検査製品の開発における継続的なイノベーション
      • 診断センターの数の増加による医療と検査へのアクセスの向上
    • 課題
      • POC脂質検査に関連する品質上の懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 POC脂質検査市場:コンポーネント別

  • イントロダクション
  • 機器
  • ソフトウェア

第7章 POC脂質検査市場:適応症別

  • イントロダクション
  • 循環器疾患
  • 高コレステロール血症
  • 高脂血症
  • タンジール病

第8章 POC脂質検査市場:エンドユーザー別

  • イントロダクション
  • 診断センター
  • 病院とクリニック

第9章 南北アメリカのPOC脂質検査市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋のPOC脂質検査市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカのPOC脂質検査市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競合ポートフォリオ

  • 主要な企業プロファイル
    • Abaxis, Inc. by Zoetis Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Callegari Srl
    • Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
    • Danaher Corporation
    • EKF Diagnostics Holdings plc
    • F. Hoffmann-La Roche Ltd.
    • General Life Biotechnology Co., Ltd.
    • Helena Laboratories Corporation
    • Menarini Group
    • Nova Biomedical
    • Quidel Corporation
    • SD Biosensor, Inc.
    • Sekisui Medical Co., Ltd.
    • Siemens AG
    • Sienco, Inc.
    • Sinocare Inc.
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech PLC
    • VivaChek Biotech(Hangzhou)Co., Ltd.
    • Werfen, S.A.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. POC LIPID TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. POC LIPID TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. POC LIPID TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. POC LIPID TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. POC LIPID TESTING MARKET DYNAMICS
  • FIGURE 7. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 8. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 10. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. POC LIPID TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 12. POC LIPID TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. POC LIPID TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. POC LIPID TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. POC LIPID TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 9. POC LIPID TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. POC LIPID TESTING MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. POC LIPID TESTING MARKET SIZE, BY HYPERLIPIDAEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. POC LIPID TESTING MARKET SIZE, BY TANGIER DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. POC LIPID TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. POC LIPID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. POC LIPID TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-DD0700E81D17

The POC Lipid Testing Market is projected to reach USD 480.15 million by 2030 from USD 299.54 million in 2022, at a CAGR of 6.07% during the forecast period.

Global POC Lipid Testing Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 299.54 million
Estimated Year Value [2023] USD 315.41 million
Forecast Year Value [2030] USD 480.15 million
CAGR (%) 6.07%
POC Lipid Testing Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the POC Lipid Testing Market.

Based on Component, market is studied across Instruments and Software. The Instruments is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia, and Tangier Disease. The Hypercholesterolemia is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Diagnostic Centers and Hospitals & Clinics. The Diagnostic Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the POC Lipid Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape POC Lipid Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the POC Lipid Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Callegari Srl, Chembio Diagnostic Systems, Inc. by BIOSYNEX SA, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., General Life Biotechnology Co., Ltd., Helena Laboratories Corporation, Menarini Group, Nova Biomedical, Quidel Corporation, SD Biosensor, Inc., Sekisui Medical Co., Ltd., Siemens AG, Sienco, Inc., Sinocare Inc., Thermo Fisher Scientific Inc., Trinity Biotech PLC, VivaChek Biotech (Hangzhou) Co., Ltd., and Werfen, S.A..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the POC Lipid Testing Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the POC Lipid Testing Market?

3. What is the competitive strategic window for identifying opportunities in the POC Lipid Testing Market?

4. What are the latest technology trends and regulatory frameworks in the POC Lipid Testing Market?

5. What is the market share of the leading vendors in the POC Lipid Testing Market?

6. Which modes and strategic moves are suitable for entering the POC Lipid Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. POC Lipid Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in prevalence of cardiovascular disease across the globe
      • 5.1.1.2. Rising investment on healthcare by private and public sector
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the production of POC lipid testing products
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in medical industry for developing point of care lipid test products
      • 5.1.3.2. Improving accessibility to healthcare and tests with rise in number of diagnostic centers
    • 5.1.4. Challenges
      • 5.1.4.1. Quality concerns associated with POC lipid testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. POC Lipid Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Software

7. POC Lipid Testing Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Hypercholesterolemia
  • 7.4. Hyperlipidaemia
  • 7.5. Tangier Disease

8. POC Lipid Testing Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals & Clinics

9. Americas POC Lipid Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific POC Lipid Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa POC Lipid Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abaxis, Inc. by Zoetis Inc.
    • 13.1.2. Abbott Laboratories
    • 13.1.3. Bio-Rad Laboratories, Inc.
    • 13.1.4. bioMerieux SA
    • 13.1.5. Callegari Srl
    • 13.1.6. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
    • 13.1.7. Danaher Corporation
    • 13.1.8. EKF Diagnostics Holdings plc
    • 13.1.9. F. Hoffmann-La Roche Ltd.
    • 13.1.10. General Life Biotechnology Co., Ltd.
    • 13.1.11. Helena Laboratories Corporation
    • 13.1.12. Menarini Group
    • 13.1.13. Nova Biomedical
    • 13.1.14. Quidel Corporation
    • 13.1.15. SD Biosensor, Inc.
    • 13.1.16. Sekisui Medical Co., Ltd.
    • 13.1.17. Siemens AG
    • 13.1.18. Sienco, Inc.
    • 13.1.19. Sinocare Inc.
    • 13.1.20. Thermo Fisher Scientific Inc.
    • 13.1.21. Trinity Biotech PLC
    • 13.1.22. VivaChek Biotech (Hangzhou) Co., Ltd.
    • 13.1.23. Werfen, S.A.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing